Perioperative medication management.
One of the consultant's roles is to make recommendations regarding the use of medications in the perioperative period. Unfortunately, the data in this area are often insufficient to provide evidence-based recommendations. In this article, we have provided advice considering the pharmacokinetics of the drug, the effect on the primary disease of stopping medications, and the effect of the medication on perioperative risk, including potential drug interactions with anesthetic agents.
Mercado
Donna L
DL
Medical Consultation Program, Baystate Medical Center, Tufts University School of Medicine, 759 Chestnut Street, Springfield, MA 01199, USA. donna.mercado@BHS.org
Petty
Brent G
BG
D019380:Anti-HIV Agents / Q000008:administration & dosage; D018501:Antirheumatic Agents / Q000008:administration & dosage; D002317:Cardiovascular Agents / Q000008:administration & dosage; D004358:Drug Therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D006401:Hematologic Agents / Q000008:administration & dosage; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D007328:Insulin / Q000008:administration & dosage; D007431:Intraoperative Complications / Q000139:chemically induced / Q000517:prevention & control; D010599:Pharmacokinetics; D008517:Phytotherapy; D011183:Postoperative Complications / Q000139:chemically induced / Q000517:prevention & control; D011300:Preoperative Care; D011619:Psychotropic Drugs / Q000008:administration & dosage; D019141:Respiratory System Agents / Q000008:administration & dosage
D019380:Anti-HIV Agents; D018501:Antirheumatic Agents; D002317:Cardiovascular Agents; D006401:Hematologic Agents; D006728:Hormones; D007328:Insulin; D011619:Psychotropic Drugs; D019141:Respiratory System Agents